Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02164851 · ClinicalTrials.gov registry record

Non-Invasive Shock: Differentiating Shock in the Emergency Department

A clinical trial, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
500
Enrollment target

NCT02164851 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 500 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02164851 has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
500 participants
Enrollment target

Study Summary

The goal of this study is to compare the characteristics of echocardiography and different monitoring devices in shock patients, the relationship of device parameters to biomarkers associated with shock, and determine if these any of these add clinical utility when predicting the cause of shock. We will perform a prospective, observational study of patients found to have shock physiology in the ED and follow them to determine the final shock category and ultimate outcomes.

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2012-11-28
Est. Completion 2020-01-01

What the Registry Record Tells You About NCT02164851

The ClinicalTrials.gov registry entry for NCT02164851 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02164851 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02164851 about?

NCT02164851 is a clinical study titled "Non-Invasive Shock: Differentiating Shock in the Emergency Department". The goal of this study is to compare the characteristics of echocardiography and different monitoring devices in shock patients, the relationship of device parameters to biomarkers associated with shock, and determine if these any of these add clinical utility when predicting the cause of shock. We ...

What is the current status of trial NCT02164851?

This trial is currently completed. The enrollment target is 500 participants. The study started on 2012-11-28. Estimated completion is 2020-01-01.

Who is sponsoring clinical trial NCT02164851?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.